JoVE Journal
Genetics
Genetics
이 콘텐츠 오픈 액세스로 구독없이 시청하실 수 있습니다.
챕터
요약
A protocol for fast CRISPR/Cas9-mediated gene disruption in mouse and human primary hematopoietic cells is described in this article. Cas9-sgRNA ribonucleoproteins are introduced via electroporation with sgRNAs generated through in vitro transcription and commercial Cas9. High editing efficiencies are achieved with limited time and financial cost.